TITLE

A Systematic Review of Provider Knowledge of Hepatitis C: Is it Enough for a Complex Disease?

AUTHOR(S)
Kyle Brown; Klaus Bielefeldt
PUB. DATE
October 2007
SOURCE
Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2550
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract  As studies indicate that patients with hepatitis C face poor provider knowledge and even stigmatization, we conducted a systematic review of provider knowledge about and attitudes toward hepatitis C. We searched Medline for original studies between 1990 and 2005. Articles were abstracted to define target population, recruitment strategies, study design, and key findings. Twenty-six publications performed in nine countries were identified. Whereas studies demonstrated an understanding of the nature of hepatitis C, significant knowledge deficits existed related to natural history, diagnostic approaches, and treatment. The relevance of simple measures, such as vaccinations against hepatitis A and B, was underappreciated. While providers were aware of risk factors for the disease, there were substantial misperceptions, with 5%–20% of providers considering casual contact as a risk for disease acquisition. We conclude that while healthcare providers understand the nature of hepatitis C, important knowledge gaps persist, which may constitute barriers to appropriate therapy.
ACCESSION #
26588673

 

Related Articles

  • Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis. Aspinall, Esther J.; Corson, Stephen; Doyle, Joseph S.; Grebely, Jason; Hutchinson, Sharon J.; Dore, Gregory J.; Goldberg, David J.; Hellard, Margaret E. // Clinical Infectious Diseases;Aug2013, Vol. 57 Issue Supp 2, pS80 

    Background. Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain reluctant to treat PWID. The aim of this review was to investigate sustained virologic response (SVR), adherence, discontinuation, and HCV...

  • Limitations of the MEDLINE Database in Constructing Meta-analyses. Leclercq, Edith; Kramer, Bianca; Schats, Winnie; Winchester, David E.; Bavry, Anthony A. // Annals of Internal Medicine;3/1/2011, Vol. 154 Issue 5, p371 

    A letter to the editor is presented in response to the article on the limitations of MEDLINE database in the establishment of meta-analyses.

  • Menopause and the influence of culture: another gap for Indigenous Australian women? Jones, Emma K.; Jurgenson, Janelle R.; Katzenellenbogen, Judith M.; Thompson, Sandra C. // BMC Women's Health;2012, Vol. 12 Issue 1, p43 

    Background: There is great variation in experience of menopause in women around the world. The purpose of this study was to review current understanding of Australian Aboriginal and Torres Strait Islander (Indigenous) women's experiences of menopause. The literature pertaining to the perception,...

  • It's all in the hands: peripheral stigmata of infective endocarditis. Ng, S. -A.; Chan, H. P.; Yeo, C. // QJM: An International Journal of Medicine;2015, Vol. 108 Issue 6, p511 

    No abstract available.

  • Factors influencing adherence in Hepatitis-C infected patients: a systematic review. Mathes, Tim; Antoine, Sunya-Lee; Pieper, Dawid // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p1 

    Background Adherence is a crucial point for the successful treatment of a hepatitis-C virus infection. Studies have shown that especially adherence to ribavirin is important. The objective of this systematic review was to identify factors that influence adherence in hepatitis-C infected patients...

  • Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force. Chou, Roger; Clark, Elizabeth C.; Helfand, Mark // Annals of Internal Medicine;3/16/2004, Vol. 140 Issue 6, p465 

    Background: Hepatitis C virus (HCV) is the most common bloodborne pathogen in the United States and is an important cause of patient morbidity and mortality, but it is unclear whether screening to identify asymptomatic infected persons is appropriate. Purpose: To synthesize the evidence on risks...

  • Hepatitis C virus and lichen planus. Lodi, Giovanni // Evidence-Based Dentistry;Mar2006, Vol. 7 Issue 1, p18 

    Data sources Medline (1966–June 2003) provided the primary data source, with references from identified papers then being reviewed for additional studies.Study selection Studies were included if they reported prevalence of hepatitis C virus (HCV) in people who have oral lichen planus...

  • Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harris, Magdalena; Rhodes, Tim // Harm Reduction Journal;2013, Vol. 10 Issue 1, p1 

    Background: Evidence documents successful hepatitis C virus (HCV) treatment outcomes for people who inject drugs (PWID) and interest in HCV treatment among this population. Maximising HCV treatment for PWID can be an effective HCV preventative measure. Yet HCV treatment among PWID remains...

  • Stigma management: How to deal with other's reactions.  // Addiction Letter;Dec93, Vol. 9 Issue 12, following p4 

    Discusses stigma management. Definition of stigmatization; Five approaches to stigma management; Disclosure; Support by association; Changing the frame of reference; Evoking compassion; Direct confrontation.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics